Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Sep 26:2024.09.19.24313917.
doi: 10.1101/2024.09.19.24313917.

High Seroprevalence to Aedes-borne arboviruses in Ethiopia: a Cross-sectional Survey in 2024

Affiliations

High Seroprevalence to Aedes-borne arboviruses in Ethiopia: a Cross-sectional Survey in 2024

Daniel M Parker et al. medRxiv. .

Update in

Abstract

Aedes-borne diseases infect millions of people each year. In the last decade several arbovirus outbreaks have been reported in Ethiopia. Arbovirus diagnosis and surveillance is lacking and the true burden is unknown. In this study we conducted a seroprevalence survey using a commercially available test kit that that tests for immunological responses to IgM and IgG for dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV) viruses in Dire Dawa city, eastern Ethiopia. We found a high IgG seroprevalence for DENV (76%), CHIKV (44%), and ZIKV (38%), and <20% IgM seropositivity across all viruses. As a comparison, we conducted serosurveillance in Addis Ababa, the national capital with no reported history of arbovirus outbreaks. The highest seropositivity we found was to IgM for DENGV at approximately 3%. Our results suggest both past and recent widespread exposure to these arboviruses, underscoring the need for improved surveillance and public health interventions in Ethiopia.

Keywords: Aedes aegypti; Ethiopia; Zika; arbovirus; chikungunya; dengue; seroprevalence.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Age specific probability of IgG and IgM seropositivity from the GEE models
Figure 2:
Figure 2:
Spearman correlation matrix for correlations between IgG and IgM for each arbovirus

References

    1. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507. doi: 10.1038/nature12060 - DOI - PMC - PubMed
    1. Chikungunya fact sheet. Accessed August 26, 2024. https://www.who.int/news-room/fact-sheets/detail/chikungunya
    1. Staples JE, Breiman RF, Powers AM. Chikungunya Fever: An Epidemiological Review of a Re-Emerging Infectious Disease. Clinical Infectious Diseases. 2009;49(6):942–948. doi: 10.1086/605496 - DOI - PubMed
    1. Mora-Salamanca AF, Porras-Ramírez A, De la Hoz Restrepo FP. Estimating the burden of arboviral diseases in Colombia between 2013 and 2016. International Journal of Infectious Diseases. 2020;97:81–89. doi: 10.1016/j.ijid.2020.05.051 - DOI - PubMed
    1. Zika virus. Accessed August 26, 2024. https://www.who.int/news-room/fact-sheets/detail/zika-virus

Publication types